Cochrane Abstracts
Antiepileptic drugs for the primary and secondary prevention of seizures after intracranial venous thrombosis
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Antiepileptic Drugs for the Primary and Secondary Prevention of Seizures After Intracranial Venous Thrombosis." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/433292/all/Antiepileptic_drugs_for_the_primary_and_secondary_prevention_of_seizures_after_intracranial_venous_thrombosis. Accessed 19 April 2024.
Antiepileptic drugs for the primary and secondary prevention of seizures after intracranial venous thrombosis. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/433292/all/Antiepileptic_drugs_for_the_primary_and_secondary_prevention_of_seizures_after_intracranial_venous_thrombosis. Accessed April 19, 2024.
Antiepileptic drugs for the primary and secondary prevention of seizures after intracranial venous thrombosis. In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/433292/all/Antiepileptic_drugs_for_the_primary_and_secondary_prevention_of_seizures_after_intracranial_venous_thrombosis
Antiepileptic Drugs for the Primary and Secondary Prevention of Seizures After Intracranial Venous Thrombosis [Internet]. In: Cochrane Abstracts. [cited 2024 April 19]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/433292/all/Antiepileptic_drugs_for_the_primary_and_secondary_prevention_of_seizures_after_intracranial_venous_thrombosis.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Antiepileptic drugs for the primary and secondary prevention of seizures after intracranial venous thrombosis
ID - 433292
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/433292/all/Antiepileptic_drugs_for_the_primary_and_secondary_prevention_of_seizures_after_intracranial_venous_thrombosis
DB - Evidence Central
DP - Unbound Medicine
ER -
